科研之友
微信
新浪微博
Facebook
分享链接
摘要
BackgroundTo validate the usefulness of subacromial bursa lidocaine for determination of the therapeutic steroid injection site in patients with adhesive capsulitis MethodsNinety-two patients with adhesive capsulitis were randomly divided into the LC (lidocaine test) group (n=46), in which LC injection was performed at the subacromial bursa prior to therapeutic steroid injection, and GH (glenohumeral) group (n=46), in which the steroid was injected into the GH. Patients in the LC group received steroid injection at the subacromial bursa or GH according to the result of the LC. Both groups underwent the same exercise protocol. Improvement of the shoulder pain was checked at 2 weeks and 3 months postinjection and expressed on an ordinal scale. Passive range of motion was recorded preinjection, and 2 weeks and 3 months postinjection. ResultsTwo weeks postinjection, 37 patients expressed much improved and 7 patients expressed slightly improved pain levels in the LC group, whereas 18 patients each expressed much improved and slightly improved pain levels in the GH group, which was significantly different (p<0.01). This difference was maintained 3 months postinjection (p<0.01). Passive range of motion in all directions improved significantly 3 months postinjection in both the LC and GH groups (p<0.01). However, there was no significant difference between the LC and GH groups. ConclusionsWe found that subacromial lidocaine injection prior to steroid injection resulted in better improvement of pain than conventional GH injection for patients with adhesive capsulitis.
- 出版日期2015-8
